WallStreetZenWallStreetZen

NASDAQ: SION
Sionna Therapeutics Inc Stock Ownership - Who owns Sionna Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Sionna Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jennifer FitzpatrickChief Legal Officer2026-03-0510,250$33.86
$347.01kSell
Jennifer FitzpatrickChief Legal Officer2026-03-0510,250$6.11
$62.63kBuy
Orbimed Advisors LLCDirector2026-02-0329,063$44.58
$1.30MSell
Peter A. ThompsonDirector2026-02-0329,063$44.58
$1.30MSell
Peter A. ThompsonDirector2026-02-021,890$44.57
$84.24kSell
Orbimed Advisors LLCDirector2026-02-021,890$44.57
$84.24kSell
Tpg GP A LLC10% Owner2026-01-22250,000$40.00
$10.00MSell
Peter A. ThompsonDirector2025-12-2433,356$44.55
$1.49MSell
Orbimed Advisors LLCDirector2025-12-2433,356$44.55
$1.49MSell
Peter A. ThompsonDirector2025-12-19875$44.49
$38.93kSell

1 of 16

SION insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SION insiders and whales buy or sell their stock.

SION Shareholders

What type of owners hold Sionna Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP22.01%9,905,045$355.00MInstitution
Peter A. Thompson16.08%7,235,661$259.33MInsider
Tpg GP A LLC14.99%6,744,962$241.74MInstitution
Tpg GP A LLC14.43%6,494,962$232.78MInsider
Atlas Venture Fund XI LP8.21%3,694,020$132.39MInsider
Orbimed Advisors LLC7.92%3,561,655$127.65MInstitution
Orbimed Advisors LLC7.85%3,530,702$126.54MInsider
Viking Global Investors LP7.10%3,195,181$114.52MInstitution
Atlas Venture Life Science Advisors LLC6.66%2,995,602$107.36MInstitution
Bruce Booth6.66%2,995,602$107.36MInsider

1 of 3

SION vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SION64.00%36.00%Net SellingNet Selling
NRIX93.03%6.97%Net SellingNet Selling
IOVA19.44%80.56%Net SellingNet Selling
NTLA72.54%27.46%Net BuyingNet Buying
OCS31.17%0.00%
View Top Biotech Stocks

Sionna Therapeutics Stock Ownership FAQ

Who owns Sionna Therapeutics?

Sionna Therapeutics (NASDAQ: SION) is owned by 97.67% institutional shareholders, 54.95% Sionna Therapeutics insiders, and 0.00% retail investors. Peter A. Thompson is the largest individual Sionna Therapeutics shareholder, owning 7.24M shares representing 16.08% of the company. Peter A. Thompson's Sionna Therapeutics shares are currently valued at $248.91M.

If you're new to stock investing, here's how to buy Sionna Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.